Synthesis and biological activities of 2-functionalized purine nucleosides

Nucleosides, Nucleotides and Nucleic Acids

Volumn 22, Issue 2, 2003, Pages 115-127

  Nair, Vasu ^a,b   Bera, Bindu ^b   Kern, Earl R ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b E11 SSH   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Antiviral activity; Functionalized purine nucleosides; IMPDH

Indexed keywords

2 (2 FLUOROVINYL)INOSINE; 2 (3 FLUOROPROPYNYL)INOSINE; 2 ETHYNYLINOSINE; 2 VINYLINOSINE; 6 CHLORO 2 (2 FLUOROVINYL)PURINE RIBOSIDE; 6 CHLORO 2 (3 FLUOROPROPYNYL)PURINE RIBOSIDE; 6 CHLORO 2 ETHYNYLPURINE RIBONUCLEOSIDE; INOSINATE DEHYDROGENASE; PURINE NUCLEOSIDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CHEMICAL REACTION; CONTROLLED STUDY; DECHLORINATION; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROLYSIS; IC 50; METHODOLOGY; NONHUMAN; REACTION ANALYSIS; VACCINIA VIRUS;

ANTIVIRAL AGENTS; CATALYSIS; ENZYME INHIBITORS; IMP DEHYDROGENASE; MODELS, CHEMICAL; PHOSPHORYLATION; PURINE NUCLEOSIDES;

VACCINIA; VACCINIA VIRUS;

EID: 0037267062     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120019498     Document Type: Article

References (39)

1. Sintchak, M.D.; Nimmesgern, E. Immunopharmacology 2000, 47, 163-184.
2. Hedstrom, L. Curr. Med. Chem. 1999, 6, 545-560.
3. Franchetti, P.; Grifantini, M. Curr. Med. Chem. 1999, 6, 599-614.
4. Goldstein, B.M.; Colby, T.D. Curr. Med. Chem. 1999, 6, 519-536.
5. Pankiewicz, K.W. Exp. Opin. Ther. Patents 1999, 9, 55-65.
6. Zimmermann, A.G.; Gu, J-J.; Laliberte, J.; Mitchell, B.S. Prog. Nucl. Acid Res. Mol. Biol. 1998, 61, 181-209.
7. (a) Smith, R.A.; Kirkpatrick, W. Eds. Ribavirin, A Broad Spectrum Antiviral Agent; Academic Press: New York, 1980;
8. (b) De Clercq, E.; Cools, M.; Balzarini, J.; Snoeck, R.; Andrei, G.; Hosoya, M.; Shigeta, S.; Ueda, T.; Minakawa, M.; Mastuda, A. Antimicrob. Agents Chemother. 1991, 35, 679-684;
9. (c) Rankin, J.T. Jr.; Eppe, S.B.; Antczak, J.B.; Joklik, W.K. Virology 1989, 168, 147-158;
10. (d) Sidwell, R.W.; Huffmann, J.H.; Khare, G.P.; Allen, L.B.; Witkowski, J.T.; Robins, R.K. Science, 1972, 177, 705-706.
11. Shuto, S.; Obara, T.; Toriya, M.; Hosoya, M.; Snoeck, R.; Andrie, G.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1992, 35, 324-331.
12. (a) Mizuno, K.; Tsujino, M.; Takada, M.; Hayashi, M.; Atsumi, K. J. Antibiotics 1974, 27, 775-782;
13. (b) Sakaguchi, K.; Tsujino, M.; Yoshizawa, M.; Mizuno, K.; Hayano, K. Cancer Res. 1975, 35, 1643-1648;
14. (c) Shiraki, K.; Ishibashi, M.; Okuno, T.; Kokado, Y.; Takahara, S.; Yamanishi, K.; Sonoda, T.; Takahashi, M. Transplant. Proc. 1990, 22, 1682-1685.
15. (a) Nair, V.; Turner, G.A.; Chamberlain, S.D. J. Am. Chem. Soc. 1987, 109, 7223-7224;
16. (b) Nair, V.; Turner, G.A.; Buenger, G.S.; Chamberlain, S.D. J. Org. Chem. 1988, 53, 3051-3057.
17. Nair, V.; Ussery, M.A. Antiviral Res. 1992, 19, 173-178.
18. Suckling, C.J. Angew. Chem. Int. Ed. 1988, 27, 537-552.
19. Thorand, S.; Krause, N. J. Org. Chem. 1998, 63, 8551-8553.
20. Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 50, 4467-4470.
21. Peters, D.; Hornfeldt, A.B.; Gronowitz, S. J. Heterocycl. Chem. 1991, 28, 1629-1631.
22. (a) Charette, A.B.; Giroux, A. J. Org. Chem. 1996, 61, 8718-8719;
23. (b) Hildebrand, J.P.; Marsden, S.P. Synlett 1996, 9, 893-894;
24. (c) Wang, X.-Z.; Deng, M.-Z. J. Chem. Soc. Perkin Trans. 1996, 22, 2663-2664;
25. (d) Charette, A.B.; De Freitas-Gil, R.P. Tetrahedron Lett. 1997, 38, 2809-2812;
26. (e) Zhou, S.-M.; Yan, Y.-L.; Deng, M.-Z. Synlett 1998, 198-200;
27. (f) Luithle, J.E.A.; Pietruszka, J. J. Org. Chem. 1999, 64, 8287-8297.
28. Soderquist, J.A.; Huertas, R.; Leon-Colon, G. Tetrahedron Lett. 2000, 41, 4251-4255.
29. (a) Cox, D.G.; Gurusamy, N.; Burton, D.J. J. Am. Chem. Soc. 1985, 107, 2811-2812;
30. (b) Kataoka, K.; Tsuboi, S. Synthesis, 2000, 452-456.
31. (a) Hanna, N.B.; Ramasamy, K.; Robins, R.K.; Revankar, G.R. J. Heterocyclic Chem. 1988, 25, 1899-1903;
32. (b) Wang, P.; Gullen, B.; Newton, M.G.; Cheng, Y-C.; Schinazi, R.F.; Chu, C.K. J. Med. Chem. 1999, 42, 3390-3399.
33. Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319-4347.
34. Nair, V.; Sells, T.B. Synlett 1991, 753-754.
35. Pal, S.; Bera, B.; Nair, V. Bioorg. Med. Chem. 2002, 10, 3615-3618.
36. Smee, D.F.; Huggins, J.W. Antiviral Res. 1998, 37, A89.
37. Neyts, J.; DeClercq, E.J. Med. Virol. 1993, 41, 242-246.
38. De Clercq, E. Clin. Microbiol. Rev. 2001, 14, 382-397.
39. Kern, E.R.; Hartline, C.; Harden, E.; Keith, K.; Rodriguez, N.; Beadle, J.R.; Hostetler, K.Y. Antimicrob. Agents Chemother. 2002, 46, 991-995.